This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (339)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Asthma  • Evidence-Based Medicine  • Allergy  • Alert me on articles by topic

A Systematic Review and Meta-analysis

Brian J. Lipworth, MD, FRCPE

Arch Intern Med. 1999;159:941-955.

Objective  To appraise the data on systemic adverse effects of inhaled corticosteroids.

Methods  A computerized database search from January 1, 1966, through July 31, 1998, using MEDLINE, EMBASE, and BIDS and using appropriate indexed terms. Reports dealing with the systemic effects of inhaled corticosteroids on adrenal gland, growth, bone, skin, and eye, and reports on pharmacology and pharmacokinetics were reviewed where appropriate. Studies were included that contained evaluable data on systemic effects in healthy volunteers as well as in asthmatic children and adults. A statistical meta-analysis using regression was performed for parameters of adrenal suppression in 27 studies.

Results  Marked adrenal suppression occurs with high doses of inhaled corticosteroid above 1.5 mg/d (0.75 mg/d for fluticasone propionate), although there is a considerable degree of interindividual susceptibility. Meta-analysis showed significantly greater potency for dose-related adrenal suppression with fluticasone compared with beclomethasone dipropionate, budesonide, or triamcinolone acetonide, whereas prednisolone and fluticasone propionate were approximately equivalent on a 10:1-mg basis. Inhaled corticosteroids in doses above 1.5 mg/d (0.75 mg/d for fluticasone propionate) may be associated with a significant reduction in bone density, although the risk for osteoporosis may be obviated by postmenopausal estrogen replacement therapy. Although medium-term growth studies showed suppressive effects with 400-µg/d beclomethasone dipropionate, there was no evidence to support any significant effects on final adult height. Long-term, high-dose inhaled corticosteroid exposure increases the risk for posterior subcapsular cataracts, and, to a much lesser degree, the risk for ocular hypertension and glaucoma. Skin bruising is most likely to occur with high-dose exposure, which correlates with the degree of adrenal suppression.

Conclusions  All inhaled corticosteroids exhibit dose-related systemic adverse effects, although these are less than with a comparable dose of oral corticosteroids. Meta-analysis shows that fluticasone propionate exhibits greater dose-related systemic bioactivity compared with other available inhaled corticosteroids, particularly at doses above 0.8 mg/d. The long-term systemic burden will be minimized by always trying to achieve the lowest possible maintenance dose that is associated with optimal asthmatic control and quality of life.

From the Department of Clinical Pharmacology and Therapeutics and Respiratory Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland.

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(9):1015-1016.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Global strategy for asthma management and prevention: GINA executive summary
Bateman et al.
Eur Respir J 2008;31:143-178.
ABSTRACT | FULL TEXT  

Fracture Risk in Patients With Chronic Lung Diseases Treated With Bronchodilator Drugs and Inhaled and Oral Corticosteroids
Vestergaard et al.
Chest 2007;132:1599-1607.
ABSTRACT | FULL TEXT  

Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies
Nieto et al.
Arch Intern Med 2007;167:2047-2053.
ABSTRACT | FULL TEXT  

Effect of choline chloride in allergen-induced mouse model of airway inflammation
Mehta et al.
Eur Respir J 2007;30:662-671.
ABSTRACT | FULL TEXT  

Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and the Risk of Hospitalization for Pneumonia
Ernst et al.
Am. J. Respir. Crit. Care Med. 2007;176:162-166.
ABSTRACT | FULL TEXT  

Exogenous Cushing Syndrome with Inhaled Fluticasone in a Child Receiving Lopinavir/Ritonavir
Bhumbra et al.
The Annals of Pharmacotherapy 2007;41:1306-1309.
ABSTRACT | FULL TEXT  

Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone
Paton et al.
Arch. Dis. Child. 2006;91:808-813.
ABSTRACT | FULL TEXT  

Side Effects With Inhaled Corticosteroids: The Physician's Perception
Irwin and Richardson
Chest 2006;130:41S-53S.
ABSTRACT | FULL TEXT  

Developing the Ideal Inhaled Corticosteroid
Cerasoli
Chest 2006;130:54S-64S.
ABSTRACT | FULL TEXT  

Osteoporosis in Men
Wright
J Am Acad Orthop Surg 2006;14:347-353.
ABSTRACT | FULL TEXT  

Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Ernst et al.
Eur Respir J 2006;27:1168-1174.
ABSTRACT | FULL TEXT  

Ciclesonide Reduces the Need for Oral Steroid Use in Adult Patients With Severe, Persistent Asthma
Bateman et al.
Chest 2006;129:1176-1187.
ABSTRACT | FULL TEXT  

Suppression of HPA axis in adults taking inhaled corticosteroids.
Greenfield and Samaras
Thorax 2006;61:272-273.
FULL TEXT  

Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease
van der Palen et al.
Thorax 2006;61:29-33.
ABSTRACT | FULL TEXT  

Allergic rhinitis.
Plaut and Valentine
NEJM 2005;353:1934-1944.
FULL TEXT  

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.
Rhen and Cidlowski
NEJM 2005;353:1711-1723.
FULL TEXT  

Long-Acting Bronchodilator or Leukotriene Modifier as Add-on Therapy to Inhaled Corticosteroids in Persistent Asthma?
Currie et al.
Chest 2005;128:2954-2962.
ABSTRACT | FULL TEXT  

Designer Inhaled Corticosteroids: Are They Any Safer?
Lipworth
Chest 2005;128:1081-1084.
FULL TEXT  

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma
Szefler et al.
Chest 2005;128:1104-1114.
ABSTRACT | FULL TEXT  

Inhaled Beclomethasone Dipropionate Acutely Stimulates Dose-Dependent Growth Hormone Secretion in Healthy Subjects
Bertoldo et al.
Chest 2005;128:902-905.
ABSTRACT | FULL TEXT  

Preclinical Profile of Ciclesonide, a Novel Corticosteroid for the Treatment of Asthma
Belvisi et al.
J. Pharmacol. Exp. Ther. 2005;314:568-574.
ABSTRACT | FULL TEXT  

Iatrogenic Cushing's Syndrome with Osteoporosis and Secondary Adrenal Failure in Human Immunodeficiency Virus-Infected Patients Receiving Inhaled Corticosteroids and Ritonavir-Boosted Protease Inhibitors: Six Cases
Samaras et al.
J. Clin. Endocrinol. Metab. 2005;90:4394-4398.
ABSTRACT | FULL TEXT  

Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease
Cooper and Tashkin
BMJ 2005;330:640-644.
FULL TEXT  

Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists
Currie et al.
QJM 2005;98:171-182.
ABSTRACT | FULL TEXT  

Growth Hormone Response to Growth Hormone-Releasing Hormone Is Reduced in Adult Asthmatic Patients Receiving Long-term Inhaled Corticosteroid Treatment
Malerba et al.
Chest 2005;127:515-521.
ABSTRACT | FULL TEXT  

Review: long term use of common medications for asthma reduces exacerbations in adults
Small
Evid. Based Nurs. 2005;8:14-14.
FULL TEXT  

The Risk of Nonvertebral Fracture Related to Inhaled Corticosteroid Exposure Among Adults With Chronic Respiratory Disease
Johannes et al.
Chest 2005;127:89-97.
ABSTRACT | FULL TEXT  

Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Scanlon et al.
Am. J. Respir. Crit. Care Med. 2004;170:1302-1309.
ABSTRACT | FULL TEXT  

Adrenal Suppression with Dry Powder Formulations of Fluticasone Propionate and Mometasone Furoate
Fardon et al.
Am. J. Respir. Crit. Care Med. 2004;170:960-966.
ABSTRACT | FULL TEXT  

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: Results From Lung Health Study II
Tashkin et al.
Chest 2004;126:1123-1133.
ABSTRACT | FULL TEXT  

The use of inhaled corticosteroids during childhood: plus ca change...
Russell
Arch. Dis. Child. 2004;89:893-895.
FULL TEXT  

Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation
Hurst and Wedzicha
Postgrad. Med. J. 2004;80:497-505.
ABSTRACT | FULL TEXT  

Categorizing Asthma Severity: An Overview of National Guidelines
Colice
Clin Med Res 2004;2:155-163.
ABSTRACT | FULL TEXT  

Inhaled Corticosteroids and the Risk of Fractures in Children and Adolescents
Schlienger et al.
Pediatrics 2004;114:469-473.
ABSTRACT | FULL TEXT  

Leukotriene Modifier vs Inhaled Corticosteroid in Mild-to-Moderate Asthma: Clinical and Anti-inflammatory Effects
Perng et al.
Chest 2004;125:1693-1699.
ABSTRACT | FULL TEXT  

Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Gluck and Colice
Chest 2004;125:1859-1876.
ABSTRACT | FULL TEXT  

Adrenal Insufficiency from Inhaled Corticosteroids
White and Woodmansee
ANN INTERN MED 2004;140:W-27-W-27.
FULL TEXT  

Cushing's Syndrome Due to Interaction Between Inhaled Corticosteroids and Itraconazole
Bolland et al.
The Annals of Pharmacotherapy 2004;38:46-49.
ABSTRACT | FULL TEXT  

Risk-Benefit Value of Inhaled Glucocorticoids: A Pharmacokinetic/Pharmacodynamic Perspective
Rohatagi et al.
J Clin Pharmacol 2004;44:37-47.
ABSTRACT | FULL TEXT  

Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics
Mager et al.
J Clin Pharmacol 2003;43:1216-1227.
ABSTRACT | FULL TEXT  

Aging Bone and Osteoporosis: Strategies for Preventing Fractures in the Elderly
Ettinger
Arch Intern Med 2003;163:2237-2246.
ABSTRACT | FULL TEXT  

Inhaled Fluticasone Propionate by Diskus in the Treatment of Asthma: A Comparison of the Efficacy of the Same Nominal Dose Given Either Once or Twice a Day
Purucker et al.
Chest 2003;124:1584-1593.
ABSTRACT | FULL TEXT  

A population based case-control study of cataract and inhaled corticosteroids
Smeeth et al.
Br. J. Ophthalmol. 2003;87:1247-1251.
ABSTRACT | FULL TEXT  

Lack of Long-term Adverse Adrenal Effects From Inhaled Triamcinolone: Lung Health Study II
Eichenhorn et al.
Chest 2003;124:57-62.
ABSTRACT | FULL TEXT  

Adrenal crisis due to inhaled steroids is underestimated
Todd
Arch. Dis. Child. 2003;88:554-555.
FULL TEXT  

Stepping down inhaled corticosteroids in asthma: randomised controlled trial
Hawkins et al.
BMJ 2003;326:1115.
ABSTRACT | FULL TEXT  

Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Sim et al.
Eur Respir J 2003;21:633-636.
ABSTRACT | FULL TEXT  

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide
Rohatagi et al.
J Clin Pharmacol 2003;43:365-378.
ABSTRACT | FULL TEXT  

Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, a Corticosteroid Capable of Inhibiting VEGF Expression
Kompella et al.
IOVS 2003;44:1192-1201.
ABSTRACT | FULL TEXT  

Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test
Pescollderungg et al.
Thorax 2003;58:227-230.
ABSTRACT | FULL TEXT  

Safety Profile of Frequent Short Courses of Oral Glucocorticoids in Acute Pediatric Asthma: Impact on Bone Metabolism, Bone Density, and Adrenal Function
Ducharme et al.
Pediatrics 2003;111:376-383.
ABSTRACT | FULL TEXT  

Inhaled corticosteroids and adrenal insufficiency
Russell
Arch. Dis. Child. 2002;87:455-456.
ABSTRACT | FULL TEXT  

Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom
Todd et al.
Arch. Dis. Child. 2002;87:457-461.
ABSTRACT | FULL TEXT  

Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: The COPE Study
van der Valk et al.
Am. J. Respir. Crit. Care Med. 2002;166:1358-1363.
ABSTRACT | FULL TEXT  

Adrenal insufficiency after treatment with fluticasone
Lipworth et al.
BMJ 2002;325:836-836.
FULL TEXT  

Therapeutic Ratio of Hydrofluoroalkane and Chlorofluorocarbon Formulations of Fluticasone Propionate*
Fowler et al.
Chest 2002;122:618-623.
ABSTRACT | FULL TEXT  

Effects of Adding Either a Leukotriene Receptor Antagonist or Low-Dose Theophylline to a Low or Medium Dose of Inhaled Corticosteroid in Patients With Persistent Asthma*
Dempsey et al.
Chest 2002;122:151-159.
ABSTRACT | FULL TEXT  

Inhaled steroids in children: adrenal suppression and growth impairment
Carlsen and Gerritsen
Eur Respir J 2002;19:985-988.
FULL TEXT  

Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R)
Johnell et al.
Eur Respir J 2002;19:1058-1063.
ABSTRACT | FULL TEXT  

One-Year Trial on Safety and Normal Linear Growth with Flunisolide HFA in Children with Asthma
Gillman et al.
CLIN PEDIATR 2002;41:333-340.
ABSTRACT  

Systemic Effect Comparisons of Six Inhaled Corticosteroid Preparations
Martin et al.
Am. J. Respir. Crit. Care Med. 2002;165:1377-1383.
ABSTRACT | FULL TEXT  

Lesson of the week: Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate * Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult
Drake et al.
BMJ 2002;324:1081-1083.
FULL TEXT  

Systemic effects of inhaled steroids
LIPWORTH et al.
Thorax 2001;56:980b-981.
FULL TEXT  

Symptomatic adrenal insufficiency during inhaled corticosteroid treatment
Patel et al.
Arch. Dis. Child. 2001;85:330-334.
ABSTRACT | FULL TEXT  

Effects of Inhaled Glucocorticoids on Bone Density in Premenopausal Women
Israel et al.
NEJM 2001;345:941-947.
ABSTRACT | FULL TEXT  

Mometason Furoate Levels
Lipworth and Affrime
Chest 2001;120:1034-1035.
FULL TEXT  

Alterations of Placental Vascular Function in Asthmatic Pregnancies
CLIFTON et al.
Am. J. Respir. Crit. Care Med. 2001;164:546-553.
ABSTRACT | FULL TEXT  

Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis Commentary: Dosage needs systematic and critical review
Holt et al.
BMJ 2001;323:253-253.
ABSTRACT | FULL TEXT  

THE PROBLEM OF DOSE-RESPONSE AND THERAPEUTIC RATIO OF INHALED STEROIDS
Lipworth et al.
Am. J. Respir. Crit. Care Med. 2001;163:1758-1759.
FULL TEXT  

Inhaled Triamcinolone and Chronic Obstructive Pulmonary Disease
Lipworth et al.
NEJM 2001;344:1553-1556.
FULL TEXT  

Fluticasone and Cortisol Measurements
Lipworth et al.
Chest 2001;119:984-985.
FULL TEXT  

Systemic effects of inhaled corticosteroids are milder in asthmatic patients than in normal subjects
FABBRI and MELARA
Thorax 2001;56:165-166.
FULL TEXT  

Montelukast and Churg-Strauss syndrome
LIPWORTH et al.
Thorax 2001;56:244-244.
FULL TEXT  

The ISOLDE trial
Lipworth et al.
BMJ 2000;321:1349-1349.
FULL TEXT  

New evidence of a link between inhaled corticosteroid use and osteoporosis
Myers
CMAJ 2000;163:1335-1335.
FULL TEXT  

Other articles noted
Evid. Based Nurs. 2000;3:106-112.
FULL TEXT  

Relative Effects of Exogenous Inhaled Corticosteroids on Diurnal Cortisol Secretion
Lipworth and de Mooij
Arch Intern Med 2000;160:2549-2550.
FULL TEXT  

Invasive Pulmonary Aspergillosis Associated with High-Dose Inhaled Fluticasone
Leav et al.
NEJM 2000;343:586-586.
FULL TEXT  

Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma
Suissa et al.
NEJM 2000;343:332-336.
ABSTRACT | FULL TEXT  

Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis
SMYTH et al.
Thorax 2000;55:251-251.
FULL TEXT  

Adrenal Suppression, Evaluated by a Low Dose Adrenocorticotropin Test, and Growth in Asthmatic Children Treated with Inhaled Steroids
Kannisto et al.
J. Clin. Endocrinol. Metab. 2000;85:652-657.
ABSTRACT | FULL TEXT  

The use of inhaled corticosteroids in childhood asthma
DTB 1999;37:73-77.
ABSTRACT | FULL TEXT  

Drugs in the peri-operative period: 2 - Corticosteroids and therapy for diabetes mellitus
DTB 1999;37:68-70.
ABSTRACT | FULL TEXT